219 related articles for article (PubMed ID: 26198547)
1. Experimental determination of multiple thermodynamic and kinetic risk factors for nephrolithiasis in the urine of healthy controls and calcium oxalate stone formers: does a universal discriminator exist?
Rodgers AL; Webber D; Hibberd B
Urolithiasis; 2015 Nov; 43(6):479-87. PubMed ID: 26198547
[TBL] [Abstract][Full Text] [Related]
2. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
[TBL] [Abstract][Full Text] [Related]
3. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
Robertson WG
Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
[TBL] [Abstract][Full Text] [Related]
4. Folium pyrrosiae ingestion has no effect on the thermodynamic or kinetic urinary risk factors for calcium oxalate urolithiasis in healthy subjects: a poor prognosis for alternative treatment in this type of stone former.
Rodgers AL; Webber D; Ramsout R; Gohel MD
Urolithiasis; 2015 Feb; 43(1):21-7. PubMed ID: 25238730
[TBL] [Abstract][Full Text] [Related]
5. Do teas rich in antioxidants reduce the physicochemical and peroxidative risk factors for calcium oxalate nephrolithiasis in humans? Pilot studies with Rooibos herbal tea and Japanese green tea.
Rodgers A; Mokoena M; Durbach I; Lazarus J; de Jager S; Ackermann H; Breytenbach I; Okada A; Usami M; Hirose Y; Ando R; Yasui T; Kohri K
Urolithiasis; 2016 Aug; 44(4):299-310. PubMed ID: 26721697
[TBL] [Abstract][Full Text] [Related]
6. The effect of warfarin therapy on the charge properties of urinary prothrombin fragment 1 and crystallization of calcium oxalate in undiluted human urine.
Buchholz NP; Kim DS; Grover PK; Dawson CJ; Ryall RL
J Bone Miner Res; 1999 Jun; 14(6):1003-12. PubMed ID: 10352110
[TBL] [Abstract][Full Text] [Related]
7. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
[TBL] [Abstract][Full Text] [Related]
8. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
[TBL] [Abstract][Full Text] [Related]
9. Crystallisation properties in stone forming and normal subjects' urine diluted using a standardised procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct.
Tiselius HG; Hallin A; Lindbäck B
Urol Res; 2001 Apr; 29(2):75-82. PubMed ID: 11396732
[TBL] [Abstract][Full Text] [Related]
10. Clinical validation of urinary indole-reacted calcium oxalate crystallization index (iCOCI) test for diagnosing calcium oxalate urolithiasis.
More-Krong P; Tubsaeng P; Madared N; Srisa-Art M; Insin N; Leeladee P; Boonla C
Sci Rep; 2020 May; 10(1):8334. PubMed ID: 32433482
[TBL] [Abstract][Full Text] [Related]
11. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
Robertson WG
Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
[TBL] [Abstract][Full Text] [Related]
12. Crystal growth of calcium oxalate in urine of stone-formers and normal controls.
Achilles W; Dekanić D; Burk M; Schalk C; Tucak A; Karner I
Urol Res; 1991; 19(3):159-64. PubMed ID: 1887523
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
[TBL] [Abstract][Full Text] [Related]
14. Herbal preparations affect the kinetic factors of calcium oxalate crystallization in synthetic urine: implications for kidney stone therapy.
Rodgers AL; Webber D; Ramsout R; Gohel MD
Urolithiasis; 2014 Jun; 42(3):221-5. PubMed ID: 24648109
[TBL] [Abstract][Full Text] [Related]
15. Calcium oxalate crystallization in urine of healthy men and women: a comparative study.
Buchholz NP; Kim DS; Grover PK; Ryall RL
Scanning Microsc; 1996; 10(2):435-42; discussion 442-4. PubMed ID: 9813622
[TBL] [Abstract][Full Text] [Related]
16. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
[TBL] [Abstract][Full Text] [Related]
17. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
Bek-Jensen H; Tiselius HG
Urol Res; 1997; 25(5):365-72. PubMed ID: 9373919
[TBL] [Abstract][Full Text] [Related]
19. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
[TBL] [Abstract][Full Text] [Related]
20. The effect of preincubation of seed crystals of uric acid and monosodium urate with undiluted human urine to induce precipitation of calcium oxalate in vitro : implications for urinary stone formation.
Grover PK; Ryall RL
Mol Med; 2002 Sep; 8(9):525-35. PubMed ID: 12456991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]